NHS won’t get cutting-edge drugs unless it pays more, says AstraZeneca boss
NegativeFinancial Markets

NHS won’t get cutting-edge drugs unless it pays more, says AstraZeneca boss
AstraZeneca's CEO, Pascal Soriot, has warned that the NHS may only be able to afford cheaper, generic medicines if the UK does not increase its spending on new drugs. He pointed out that the cost-effectiveness thresholds for new medicines have remained unchanged for two decades, which could hinder access to cutting-edge treatments for patients. This situation is concerning as it highlights the potential limitations in healthcare innovation and patient care in the UK, emphasizing the need for a reevaluation of funding strategies to ensure that the NHS can provide the best possible treatments.
— via World Pulse Now AI Editorial System




